Lantz Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$568K Buy
7,267
+3,217
+79% +$260K 0.1% 165
2026
Q1
$351K Buy
4,050
+1,874
+86% +$180K 0.07% 196
2025
Q4
$209K Buy
+2,176
New +$211K 0.04% 243
2025
Q2
Sell
-2,328
Closed -$209K 240
2025
Q1
$209K Buy
+2,328
New +$208K 0.06% 208
2024
Q1
Sell
-3,434
Closed -$283K 210
2023
Q4
$283K Buy
3,434
+55
+2% +$4.19K 0.1% 164
2023
Q3
$265K Buy
3,379
+335
+11% +$28K 0.11% 155
2023
Q2
$268K Buy
3,044
+88
+3% +$7.58K 0.11% 159
2023
Q1
$238K Sell
2,956
-50
-2% -$4.08K 0.1% 164
2022
Q4
$234K Buy
+3,006
New +$244K 0.11% 159

Other funds holding MDT

Lantz Financial's MDT Position: Q2 2026 in Review

Lantz Financial increased its Medtronic (MDT) stake by 79% in Q2 2026, buying an estimated $260K and bringing the position to 7,267 shares worth $568K. The position accounts for 0.1% of the portfolio, ranked #165.

Lantz Financial first reported a position in MDT in Q4 2022 and has held it in 9 quarters since. 486 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Lantz Financial held 7,267 shares of Medtronic worth $568K as of Q2 2026.
  • Lantz Financial bought 3,217 Medtronic shares in Q2 2026, an estimated $260K.
  • Medtronic made up 0.1% of Lantz Financial's portfolio in Q2 2026, its #165 holding.
  • Lantz Financial first reported a position in Medtronic in Q4 2022 and has held it in 9 quarters since.
  • 486 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.